How has been the historical performance of Mankind Pharma?

Nov 13 2025 12:02 AM IST
share
Share Via
Mankind Pharma has shown consistent growth over the past five years, with net sales increasing from INR 6,214.43 crore in March 2021 to INR 12,207.44 crore in March 2025, and profit after tax rising from INR 1,281.35 crore to INR 1,994.35 crore. The company's earnings per share also improved from INR 28.08 to INR 48.25, reflecting enhanced shareholder value.
Answer:
The historical performance of Mankind Pharma shows a consistent growth trajectory in net sales and profits over the past five years.

Breakdown:
Mankind Pharma's net sales have increased significantly from INR 6,214.43 crore in March 2021 to INR 12,207.44 crore in March 2025. This growth is reflected in the total operating income, which rose from INR 6,214.43 crore to INR 12,207.44 crore during the same period. The company's operating profit (PBDIT) also saw a substantial increase, climbing from INR 1,819.05 crore in March 2021 to INR 3,554.72 crore in March 2025, indicating improved operational efficiency. Profit before tax has similarly grown from INR 1,679.93 crore to INR 2,504.09 crore, while profit after tax increased from INR 1,281.35 crore to INR 1,994.35 crore. The earnings per share (EPS) rose from INR 28.08 to INR 48.25, showcasing enhanced shareholder value. On the balance sheet, total assets surged from INR 6,323.62 crore in March 2021 to INR 27,651.64 crore in March 2025, with total liabilities also increasing from INR 6,323.62 crore to INR 8,483.03 crore. The cash flow from operating activities improved from INR 1,137 crore to INR 2,413 crore, although cash flow from investing activities showed a significant outflow of INR 12,624 crore in March 2025. Overall, Mankind Pharma has demonstrated robust growth in sales, profits, and asset accumulation over the past five years.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News